Kobayashi Pharmaceutical Co (FRA:KOY) Accounts Payable & Accrued Expense : €186 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Kobayashi Pharmaceutical Co Accounts Payable & Accrued Expense?

Kobayashi Pharmaceutical Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (€196 Mil) to Dec. 2023 (€246 Mil) but then declined from Dec. 2023 (€246 Mil) to Mar. 2024 (€186 Mil).

Kobayashi Pharmaceutical Co's annual accounts payable & accrued expense declined from Dec. 2021 (€272 Mil) to Dec. 2022 (€240 Mil) but then increased from Dec. 2022 (€240 Mil) to Dec. 2023 (€246 Mil).

Kobayashi Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Kobayashi Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kobayashi Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Kobayashi Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

316.15

271.75

271.76

240.47

246.02

Kobayashi Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															210.71	210.16	195.64	246.02	186.03

Kobayashi Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Kobayashi Pharmaceutical Co (FRA:KOY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kobayashi Pharmaceutical Co Ltd (FRA:KOY) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

4967:Japan

Address

KDX Kobayashi Doshomachi Building, 4-4-10 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045

Website

https://www.kobayashi.co.jp

Kobayashi Pharmaceutical Co Ltd is a consumer product company focusing on niche markets. Its portfolio ranges from OTC pharmaceuticals, household products, to body warmers, and skincare. Kobayashi mainly sells its products in drugstores, convenience stores, and general merchandise stores, or GMSes. It has a geographical presence in Japan and is expanding overseas business in the U.S., China, and Southeast Asia.

Kobayashi Pharmaceutical Co (FRA:KOY) Headlines

No Headlines